LIN YU-HSIN (Chief Executive Officer) sold 5.1% of their position (9.20K shares) of BELITE BIO, INC on the open market
Open‑market sale worth $1.67M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 4/13/2026ACC: 0001193125-26-152885
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-9.20K
Net shares
Net seller
$1.67M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
9.20K disposed
Non-Derivative Transactions4
American depositary share
Direct
Shares
−2.50K
Price / share
$180.36
Trade value
$450.89K
% of position
1.4%
4/9/2026
180.13K→177.63K
American depositary share
Direct
Shares
−3.50K
Price / share
$181.33
Trade value
$634.66K
% of position
2.0%
4/9/2026
177.63K→174.13K
American depositary share
Direct
Shares
−3K
Price / share
$182.40
Trade value
$547.19K
% of position
1.7%
4/9/2026
174.13K→171.13K
American depositary share
Direct
Shares
−200.00
Price / share
$183.00
Trade value
$36.60K
% of position
0.1%
4/9/2026
171.13K→170.93K
Total
Net shares
−9.20K
Net value
-$1.67M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American depositary share Direct | 4/9/2026 | S · Sale | −2.50K | $180.36 | $450.89K | 1.4% | 180.13K | 177.63K |
| American depositary share Direct | 4/9/2026 | S · Sale | −3.50K | $181.33 | $634.66K | 2.0% | 177.63K | 174.13K |
| American depositary share Direct | 4/9/2026 | S · Sale | −3K | $182.40 | $547.19K | 1.7% | 174.13K | 171.13K |
| American depositary share Direct | 4/9/2026 | S · Sale | −200.00 | $183.00 | $36.60K | 0.1% | 171.13K | 170.93K |
| Total | −9.20K | -$1.67M | ||||||
Derivative Transactions0
No derivative transactions reported